[PDF][PDF] Metallo-beta-Lactamase-producing Pseudomonas aeruginosa in Iran: a systematic review and meta-analysis
4 percent. Our findings also revealed that the highest prevalence of MBL-producing P.
aeruginosa was in Isfahan with 60%(95% CI: 0.27-0.86). In addition, in Iranian population …
aeruginosa was in Isfahan with 60%(95% CI: 0.27-0.86). In addition, in Iranian population …
[PDF][PDF] Prevalence and characteristics of metallo-beta-lactamase-positive and high-risk clone ST235 Pseudomonas aeruginosa at Ardabil hospitals
S Safarirad, M Arzanlou, J Mohammadshahi… - Jundishapur Journal of …, 2021 - brieflands.com
Background: Carbapenems are the most commonly administered drugs for the treatment of
multidrug-resistant Pseudomonas aeruginosa (MDR P. aeruginosa) infections. However …
multidrug-resistant Pseudomonas aeruginosa (MDR P. aeruginosa) infections. However …
Evaluation of chromosomally and acquired mechanisms of resistance to carbapenem antibiotics among clinical isolates of Pseudomonas aeruginosa in Kerman, Iran
Z Hashemizadeh, S Mansouri, F Pahlavanzadeh… - Gene Reports, 2020 - Elsevier
Introduction Multidrug-resistant (MDR) of Pseudomonas aeruginosa isolates are increasing
around the world which can cause serious problems for antimicrobial therapy in hospital …
around the world which can cause serious problems for antimicrobial therapy in hospital …
Prevalence and Antibiotic Resistance Patterns of Metallo-Beta-Lactamase-Producing Pseudomonas aeruginosa Isolated from Patients in a Hospital in Zabol …
Background: Treatment of infections caused by metallo-beta-lactamase (MBL)-producing
Pseudomonas aeruginosa (P. aeruginosa) is a major healthcare-associated concern …
Pseudomonas aeruginosa (P. aeruginosa) is a major healthcare-associated concern …